AgnesFogo United States

Institution

Day 1 - Sunday April 14, 2024

Time Session
11 a.m.
12 p.m.
Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria)
PL2
AgnesFogo Chairperson United States
GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology
  • My Story
    VictoriaGray Speaker vwright_03@yahoo.comUnited States
  • CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture
    Obiageli EuniceNnodu Speaker oennodu@gmail.comNigeriaUniversity of Abuja
Hall A

Pre-Congress - Saturday April 13, 2024

Time Session
9 a.m.
11 a.m.
Renal Pathology Course: New Insights in Glomerular Disease: Part 1
PATH1
CarmenAvila Casado Chairperson CanadaUniversity of Toronto, UHN
ValeriaAlberton Chairperson vgalberton@gmail.comArgentinaHospital Fernandez/ Hospital El Cruce
WesamIsmail Chairperson wesam_ismail@yahoo.comEgyptHead of Pathology Department, Beni Suef University
  • Updates in Genetic Testing in Renal Disease
    PATH1-01
    DanicaGalešić Ljubanović Speaker danica.ljubanovic@mef.hrCroatiaUniversity of Zagreb, School of Medicine, Department of Pathology and Dubrava University Hospital, Zagreb, Croatia
  • Classification of Lupus
    PATH1-02
    AgnesFogo Speaker United States
  • New Insights in Membranous Nephropathy
    PATH1-03
    SanjeevSethi Speaker United StatesMayo Clinic
  • Amyloidosis Update
    PATH1-04
    WesamIsmail Speaker wesam_ismail@yahoo.comEgyptHead of Pathology Department, Beni Suef University
  • Q and A
    PATH1-05
Hall C1